drugset / Trial / NCT07123259

Ulcer Pomegranate Muffins

NCT07123259 ↗

Completed 82 enrolled University of Lahore
RandomizedParallel-groupSingle-blindSupportive care

Summary

Pomegranate (Punica granatum L.) peel powder, known for its potent antioxidant, anti-inflammatory, and antimicrobial properties, has shown promise in the dietary management of gastrointestinal disorders. In recent clinical observations, incorporating pomegranate peel powder into muffins consumed by patients with gastric ulcers demonstrated potential anti-ulcerative colitis activity. The bioactive compounds in the peel, such as polyphenols (punicalagins, ellagic acid), help reduce oxidative stress and modulate inflammatory pathways in the gut. Patients consuming these enriched muffins reported improvements in gastrointestinal symptoms, reduced mucosal inflammation, and enhanced mucosal healing, suggesting a supportive role of pomegranate peel as a functional food ingredient in managing gastric and colitis-related conditions.

Timeline

Start
2024-08-10
Primary completion
2024-10-10
Completion
2024-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject pomegranate peel powder Unknown 1.5 g —
Subject pomegranate peel powder Unknown 3 g —